Targeting protein kinase ck2: evaluating cx-4945 potential for gl261 glioblastoma therapy in immunocompetent mice

HIGHLIGHTS

• who: Laura Ferrer-Font and collaborators from the Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Cerdanyola del VallÙs, Spain Department of Biomedical Sciences, University of Padova, Padova, Italy have published the Article: Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice, in the Journal: (JOURNAL)
• what: The authors have evaluated iCK2 effects over cultured GL261 cells viability to select the best candidates for in_vivo preclinical studies. The authors could demonstrate that 3 days of CX-4945 administration to GL261 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.